Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
---|
03/10/2004 | EP1395557A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
03/10/2004 | EP1395556A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
03/10/2004 | EP1395555A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
03/10/2004 | EP1136477B1 Benzofuran derivatives, process for the preparation of the same and uses thereof |
03/10/2004 | CN1141093C Anticancer lichee lectone medicine and its prepn |
03/04/2004 | US20040044051 Cannabinoid receptor agonists |
03/04/2004 | US20040044015 Quinazoline derivatives |
03/03/2004 | EP1394161A1 L−ASCORBIC ACID−2−O−MALEIC ACID−A−TOCOPHEROL DIESTER 1−PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME |
03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
03/03/2004 | EP1087780B1 Extraction method of a compound from vegetable material |
03/03/2004 | EP0841916B9 Endothelin receptor antagonists |
03/03/2004 | CN1479728A Pexoxisome proliferator activated receptor alpha agonists |
03/02/2004 | US6700013 O-bromophenylacetic acid derivative chemical intermediate; smooth muscle relaxants, antiinflammatory agents; respiratory system disorders |
03/02/2004 | US6699860 Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists |
02/26/2004 | WO2003059898A3 Eponemycin and epoxomicin analogs and uses thereof |
02/26/2004 | US20040039049 Stable amorphous calcium pseudomonate and processes for the preparation thereof |
02/26/2004 | US20040039016 HIV protease inhibitors |
02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
02/26/2004 | US20040038957 Anti-malarial activity |
02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
02/25/2004 | EP1230232B1 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
02/25/2004 | EP1210326B1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
02/24/2004 | CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
02/19/2004 | WO2004014919A1 Epothilone derivatives |
02/19/2004 | WO2004014886A1 Antigiardial agents and use thereof |
02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
02/19/2004 | WO2004014372A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
02/19/2004 | WO2003065975A3 Processes for preparing crystalline and amorphous mupirocin calcium |
02/19/2004 | US20040034239 Inhibitors of nadh:ubiquinone oxidoreductase |
02/19/2004 | US20040034230 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent |
02/19/2004 | US20040034049 A benzofuran derivatives for treating neurodegenerative disease, such as Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis and Huntington's disease |
02/19/2004 | US20040034047 E.g. 5-(6,7-dimethoxy-2-(4-methoxybenzyl)benzofuran-4-yl-methyl-)pyrimidine-2,4 -diamine; bactericides for infections of grampositive and gramnegative pathogens; more potent than Trimethoprim, especially against respiratory tract pathogens |
02/19/2004 | US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings |
02/19/2004 | CA2494259A1 Epothilone derivatives |
02/18/2004 | EP1389202A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
02/18/2004 | CN1476436A Novel compounds for use as HIV protease inhibitors |
02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
02/17/2004 | US6692657 Alkenyl compound with 2,3-difluorophenyl group |
02/12/2004 | WO2004013153A2 Macrolide compounds endowed with antiinflammatory activity |
02/12/2004 | WO2004013120A1 Novel benzodioxoles |
02/12/2004 | WO2004013093A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
02/12/2004 | WO2004012656A2 Thiophene and furan derivatives as prostaglandin agonists and use thereof |
02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
02/12/2004 | US20040029874 Anticoagulants; cardiovascular disorders |
02/12/2004 | CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
02/11/2004 | EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
02/11/2004 | EP1387679A1 Sulfonamides |
02/11/2004 | CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
02/10/2004 | US6689891 2-bromomethyl-6-methyl-benzoic acid and a process for the preparation thereof |
02/10/2004 | US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
02/05/2004 | WO2004011661A1 Novel physiologically active substances |
02/05/2004 | WO2004011459A1 Novel physiologically active substance |
02/05/2004 | WO2004011458A1 Total synthesis of myriaporones |
02/05/2004 | US20040024190 Viral polymerase inhibitors |
02/05/2004 | US20040024052 Processes for preparing crystalline and amorphous mupirocin calcium |
02/05/2004 | US20040024051 C10 heterosubstituted acetate taxanes |
02/05/2004 | US20040024049 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
02/05/2004 | US20040024024 Inhibiting matrix metalloproteinase and aggrecanase activity; for treatment of strokes and neurodegenerative diseases |
02/05/2004 | US20040023958 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus. |
02/05/2004 | US20040023945 Cyclic amp-specific phosphodiesterase inhibitors |
02/05/2004 | CA2494532A1 Total synthesis of myriaporones |
02/04/2004 | EP1385838A1 Piperazino-derivatives and their use as pde4 inhibitor |
02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
02/04/2004 | EP1042319B1 Dihydrobenzofurans |
02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
02/03/2004 | US6686483 Reacting an oxidizer with an olefin in presence of ketone |
02/03/2004 | US6685995 Low voltage, wide temperature range driving; high speed response |
01/29/2004 | WO2004009544A1 2-cyano-4-fluoropyrrolidine derivative or its salt |
01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
01/29/2004 | CA2493339A1 2-cyano-4-fluoropyrrolidine derivative or salt thereof |
01/28/2004 | EP1384721A1 Stable amorphous calcium pseudomonate and processes for the preparation thereof |
01/28/2004 | EP1383757A1 Antagonists of mcp-1 function and methods of use thereof |
01/28/2004 | EP1383756A1 Coumarin derivatives to be used as anticoagulants |
01/28/2004 | CN1471521A Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
01/28/2004 | CN1471520A Aminoalkyl benzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
01/27/2004 | US6683196 Reacting racemic beta-lactam with lithium- 7-protected baccatin iii- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents |
01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
01/27/2004 | CA2256247C New naphtalene compounds, their preparation and pharmaceutical compositions containing them |
01/25/2004 | CA2429287A1 Stable amorphous calcium pseudomonate and processes for the preparation thereof |
01/22/2004 | WO2004007458A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
01/22/2004 | US20040014979 For use as antitumor agents |
01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
01/22/2004 | CA2492100A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
01/21/2004 | EP1381359A1 Aurones as telomerase inhibitors |
01/21/2004 | EP1313749A4 Process for preparation of anhydrous azithromycin |
01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
01/20/2004 | CA2303498C Dioxocyclopentyl hydroxamic acids |
01/15/2004 | WO2004005917A1 Fluorescent probe |
01/15/2004 | WO2004005252A1 Azabicyclo derivatives as muscarinic receptor antagonists |
01/15/2004 | WO2004004726A1 Mchir antagonists |
01/15/2004 | WO2004004629A2 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
01/15/2004 | US20040010011 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
01/15/2004 | CA2492121A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |